英文名稱(chēng) Anti-ATP6V1G2/FITC

中文名稱(chēng) :FITC標(biāo)記的氫離子轉(zhuǎn)運(yùn)ATP合成酶6G抗體

規(guī)格:100ul

說(shuō)明書(shū) 100ul  

研究領(lǐng)域腫瘤  細(xì)胞生物  免疫學(xué)  信號(hào)轉(zhuǎn)導(dǎo)  

抗體來(lái)源Rabbit

克隆類(lèi)型Polyclonal

交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Horse,

產(chǎn)品應(yīng)用Flow-Cyt=1:50-200 IF=1:50-200  

not yet tested in other applications.

optimal dilutions/concentrations should be determined by the end user.

分子量14kDa

性    狀Lyophilized or Liquid

濃    度1mg/ml

免疫原KLH conjugated synthetic peptide derived from human ATP6V1G2/V-ATPase G2

亞    型IgG

純化方法affinity purified by Protein A

儲(chǔ)存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

保存條件Store at -20 °C for one year.

別　名　ATP6G; ATP6G2; ATPase H+ transporting lysosomal (vacuolar proton pump) subunit G; ATPase H+ transporting lysosomal 13kDa V1 subunit G2; H(+) transporting two sector ATPase subunit G2; NG 38; NG38; V ATPase 13 kDa subunit 2; V ATPase G subunit 2; V ATPase subunit G 2; Vacuolar ATP synthase subunit G 2; Vacuolar proton pump G subunit 2; Vacuolar proton pump subunit G 2; VMA 10; VMA10.